Gallium (68Ga) chloride/Germanium (68Ge) chloride

N/A

Report date: 2026/01/28 11:02:41
NME

Base Information

Drug NameGallium (68Ga) chloride/Germanium (68Ge) chloride
Drug Alias Name68Ge/68Ga GeneratorGalliaPharmGalenVitaEZR001EZR-001
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Nuclides > Germanium > 68Ge +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, NeuroendocrineNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2024/08/01
Country/TerritoryEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgEckert & Ziegler Radiopharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgEckert & Ziegler Radiopharma Gmbh
Inactive CompaniesN/A
Active IndicationsCarcinoma, NeuroendocrineNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeV09X
Related LinksN/A